Stockreport

Qualigen seeks to enter the $10 Billion CABG market with non-binding MOU to acquire Marizyme

Qualigen Therapeutics, Inc.  (QLGN) 
PDF CARLSBAD, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today they have entered a non-binding Memoran [Read more]